Caxton Associates (New York)’s Globus Medical GMED Stock Holding History

Caxton Associates (New York)’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,501	Closed	-$1.1M	–	489
2023 Q2	$1.1M	Sell	18,501 -23,089	-56%	-$1.32M	0.16%	133
2023 Q1	$2.36M	Buy	+41,590	New	+$2.67M	0.36%	37
2022 Q3	–	Sell	-13,467	Closed	-$756K	–	553
2022 Q2	$756K	Buy	13,467 +6,079	+82%	+$400K	0.07%	186
2022 Q1	$545K	Buy	+7,388	New	+$514K	0.04%	226
2021 Q3	–	Sell	-3,866	Closed	-$300K	–	498
2021 Q2	$300K	Buy	+3,866	New	+$275K	0.03%	305
2020 Q4	–	Sell	-4,732	Closed	-$234K	–	214
2020 Q3	$234K	Buy	+4,732	New	+$244K	0.02%	236
2019 Q1	–	Sell	-9,381	Closed	-$406K	–	428
2018 Q4	$406K	Buy	9,381 +395	+4%	+$19.7K	0.06%	135
2018 Q3	$510K	Buy	+8,986	New	+$473K	0.04%	228
2017 Q4	–	Sell	-15,400	Closed	-$458K	–	403
2017 Q3	$458K	Buy	+15,400	New	+$470K	0.02%	365

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Caxton Associates (New York)'s GMED Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Globus Medical (GMED) in Q3 2023, closing a stake of 18,501 shares — an estimated $1.1M sold.

Caxton Associates (New York) first reported a position in GMED in Q3 2017 and held it in 9 quarters. The position peaked at $2.36M in Q1 2023. 431 funds tracked by Wall St. Rank hold GMED as of Q3 2023.

Caxton Associates (New York) reported no remaining Globus Medical position as of Q3 2023 after selling out during the quarter.
Caxton Associates (New York) sold 18,501 Globus Medical shares in Q3 2023, an estimated $1.1M.
Caxton Associates (New York) first reported a position in Globus Medical in Q3 2017 and held it in 9 quarters.
Caxton Associates (New York)'s Globus Medical position peaked at $2.36M in Q1 2023.
431 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.